Sandler Neurosciences Building, Neurological Clinical Research Unit
Welcome,         Profile    Billing    Logout  
 1 Trial 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Green, Ari J
ReCOVER, NCT02521311 / 2018-001756-35: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis

Recruiting
2
90
US
Clemastine, Tavist, Clemastine fumarate, Walhist, Placebo
University of California, San Francisco, Moorfields Eye Hospital NHS Foundation Trust
Optic Neuritis
08/26
08/26
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
ReINFORCE, NCT06065670: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Not yet recruiting
1/2
44
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
10/26
10/26
Casillas, Daniel
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
Chapman, Makenna
ReCOVER, NCT02521311 / 2018-001756-35: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis

Recruiting
2
90
US
Clemastine, Tavist, Clemastine fumarate, Walhist, Placebo
University of California, San Francisco, Moorfields Eye Hospital NHS Foundation Trust
Optic Neuritis
08/26
08/26
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
ReINFORCE, NCT06065670: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Not yet recruiting
1/2
44
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
10/26
10/26
Ananth, Kirtana
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
Halait, Harkeerat
ReCOVER, NCT02521311 / 2018-001756-35: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis

Recruiting
2
90
US
Clemastine, Tavist, Clemastine fumarate, Walhist, Placebo
University of California, San Francisco, Moorfields Eye Hospital NHS Foundation Trust
Optic Neuritis
08/26
08/26
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
ReINFORCE, NCT06065670: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Not yet recruiting
1/2
44
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
10/26
10/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Green, Ari J
ReCOVER, NCT02521311 / 2018-001756-35: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis

Recruiting
2
90
US
Clemastine, Tavist, Clemastine fumarate, Walhist, Placebo
University of California, San Francisco, Moorfields Eye Hospital NHS Foundation Trust
Optic Neuritis
08/26
08/26
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
ReINFORCE, NCT06065670: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Not yet recruiting
1/2
44
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
10/26
10/26
Casillas, Daniel
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
Chapman, Makenna
ReCOVER, NCT02521311 / 2018-001756-35: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis

Recruiting
2
90
US
Clemastine, Tavist, Clemastine fumarate, Walhist, Placebo
University of California, San Francisco, Moorfields Eye Hospital NHS Foundation Trust
Optic Neuritis
08/26
08/26
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
ReINFORCE, NCT06065670: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Not yet recruiting
1/2
44
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
10/26
10/26
Ananth, Kirtana
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
Halait, Harkeerat
ReCOVER, NCT02521311 / 2018-001756-35: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis

Recruiting
2
90
US
Clemastine, Tavist, Clemastine fumarate, Walhist, Placebo
University of California, San Francisco, Moorfields Eye Hospital NHS Foundation Trust
Optic Neuritis
08/26
08/26
ReVIVE, NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Recruiting
1/2
74
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco, United States Department of Defense
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
06/25
06/25
ReINFORCE, NCT06065670: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Not yet recruiting
1/2
44
US
Clemastine Fumarate, Clemastine, Dayhist, Dayhist Allergy, Placebo, Sugar pill
University of California, San Francisco
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
10/26
10/26

Download Options